Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Ndufs1 ELISA Kit (AC3420)
Cat.#: ASET-2009
Specifications
Description Human Ndufs1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Ndufs1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 11.11 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2061 Rat NF-kB p65 ELISA Kit (AC3472) Quantitative inquiry ASET-1178 Mouse LRRK2 ELISA Kit (AC2589) Quantitative inquiry ASET-1125 Human APH1A ELISA Kit (AC2536) Quantitative inquiry ASET-1482 Human Ki67 ELISA Kit (AC2893) Quantitative inquiry ASET-1957 Mouse Nmur1 ELISA Kit (AC3368) Quantitative inquiry ASET-1322 Rat Thrombospondin 1 ELISA Kit (AC2733) Quantitative inquiry ASET-1755 Human NK-2R ELISA Kit (AC3166) Quantitative inquiry ASET-1464 Human L1CAM ELISA Kit (AC2875) Quantitative inquiry ASET-1759 Human FGFR1 ELISA Kit (AC3170) Quantitative inquiry ASET-2271 Human PKC delta ELISA Kit (AC3682) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket